Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT05424029
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to find out if fluid rinsed from peoples' airways (bronchial washing samples) during routine surgery to remove (resect) their non-small cell lung cancer (NSCLC) tumors contains enough vesicles to do testing that may help the researchers learn more about their NSCLC.
Key Dates
- Start date
- Jun 14, 2022
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 200 participants (estimated)
Primary Outcome Measure
to isolate exosomes from bronchial washings [ Time Frame: day 1 ]
Central Contacts
- David Jones, MD212-639-6428
- Yuan Liu, MD, PhD646-888-3640
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (Consent Only) | Basking Ridge | New Jersey | 07920 | David Jones, MD 212-639-6428 |
| Memorial Sloan Kettering Monmouth (Consent Only) | Middletown | New Jersey | 07748 | David Jones, MD 212-639-6428 |
| Memorial Sloan Kettering Bergen (Consent Only) | Montvale | New Jersey | 07645 | David Jones, MD 212-639-6428 |
| Memorial Sloan Kettering Suffolk - Commack (Consent Only) | Commack | New York | 11725 | David Jones, MD 212-639-6428 |
| Memorial Sloan Kettering Westchester (Consent Only) | Harrison | New York | 10604 | David Jones, MD 212-639-6428 |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | David Jones, MD 212-639-6428 Yuan Liu, MD, PhD 646-888-3640 David Jones, PhD (PRINCIPAL_INVESTIGATOR) |
| Memorial Sloan Kettering Nassau (Consent Only) | Uniondale | New York | 11553 | David Jones, MD 212-639-6428 |
Find similar trials in Basking Ridge, NJ
By condition
By specialty
By research site
Memorial Sloan Kettering Basking Ridge (Consent Only)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Consent Only)· Middletown, NJMemorial Sloan Kettering Bergen (Consent Only)· Montvale, NJMemorial Sloan Kettering Suffolk - Commack (Consent Only)· Commack, NYMemorial Sloan Kettering Westchester (Consent Only)· Harrison, NYMemorial Sloan Kettering Cancer Center· New York, NY
Related Studies
- Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL ActivityPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung CancerPHASE3 · Recruiting · University of Texas Southwestern Medical Center · La Jolla, California
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California
- Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2PHASE1 · Recruiting · University of Rochester · Rochester, New York